Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05425316 · ClinicalTrials.gov registry record
Speech in Hepatic Encephalopathy (HE)
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 251
- Enrollment target
NCT05425316 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 251 participants.
The verdict
NCT05425316 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 251 participants
- Enrollment target
Study Summary
This is an observational study that will test the clinical significance of speech features in patients with cirrhosis. It aims to assess if speech is associated with cognitive function at baseline, if speech predicts changes in cognition, and if speech predicts future events of hepatic encephalopathy (cirrhosis-related confusion), as well as to assess the dynamics of speech over time, especially with episodes of overt hepatic encephalopathy (OHE) and treatment interventions.
Interventions
- BEHAVIORAL Home Recordings
- BEHAVIORAL In-patient Recordings
- BEHAVIORAL Same-Day Study Visit - Regular Appointment
- BEHAVIORAL Same-Day Study Visit - Procedure
- BEHAVIORAL Phone Call Follow-up Visits
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2021-10-05 |
| Est. Completion | 2024-07-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05425316
The ClinicalTrials.gov registry entry for NCT05425316 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 251 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Home Recordings is the first listed.
NCT05425316 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05425316 about?
NCT05425316 is a clinical study titled "Speech in Hepatic Encephalopathy (HE)". This is an observational study that will test the clinical significance of speech features in patients with cirrhosis. It aims to assess if speech is associated with cognitive function at baseline, if speech predicts changes in cognition, and if speech predicts future events of hepatic encephalopath...
What is the current status of trial NCT05425316?
This trial is currently completed. The enrollment target is 251 participants. The study started on 2021-10-05. Estimated completion is 2024-07-24.
What interventions are being tested in trial NCT05425316?
The interventions under investigation include: Home Recordings (BEHAVIORAL), In-patient Recordings (BEHAVIORAL), Same-Day Study Visit - Regular Appointment (BEHAVIORAL), Same-Day Study Visit - Procedure (BEHAVIORAL), Phone Call Follow-up Visits (BEHAVIORAL).
Who is sponsoring clinical trial NCT05425316?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.